Insight

COVID-19 patients with coinfections have higher mortality rates than those with single infections

Opportunistic fungal infections present new challenges to health care providers on the front line of the pandemic

Research from this past year highlights the potential of CRISPR-Cas9 technology in modeling and treating rare disease

Even standard components can affect assay results

Routine sequencing has detected a new variant in South Africa, called B.1.1.529 or "Omicron"

Adjusting lab culture and standardizing electronic reports can facilitate the evolution toward a more connected health ecosystem

A digital solution lets laboratory staff focus on critical tasks

To keep up with emerging NPS, toxicology labs must develop robust assays and update existing testing panels and menus

A look at interlaboratory variability of exome testing and ways labs can reduce this variability to improve patient care

Cytological and molecular screening approaches improve diagnostic accuracy, efficiency, and throughput

Changes in lab values can have important long-term impacts on the health of transgender patients

Flow cytometry has proven to be an invaluable tool for developing new cell therapies

Viral SNPs can be used to track new coronavirus variants, while SNPs in patient genomes could influence clinical care

Large-scale study sheds light on how donor characteristics impact blood storage

The World Health Organization (WHO) has added another coronavirus variant to its list to monitor

Mobile testing frameworks could help deliver better health care to underserved communities

Harnessing the power of pharmacogenomics may make opioid analgesics safer and more effective

TLA allows clinical laboratories to streamline their operations, increase capacity, and minimize error

The Solve-RD consortium is striving to improve rare disease diagnostics using genomics

New hematology point-of-care devices perform as well as clinical lab testing